TTX-080 HLA-G Antagonist in Subjects With Advanced Cancers
Tizona Therapeutics, Inc
Tizona Therapeutics, Inc
University of Chicago
Memorial Sloan Kettering Cancer Center
Fate Therapeutics
Hoffmann-La Roche
ISU Abxis Co., Ltd.
Orient Europharma Co., Ltd.
National Institutes of Health Clinical Center (CC)
University of Colorado, Denver
Eli Lilly and Company
Georgetown University
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Abramson Cancer Center at Penn Medicine
Masonic Cancer Center, University of Minnesota
Bristol-Myers Squibb
Hoffmann-La Roche
Merrimack Pharmaceuticals
Memorial Sloan Kettering Cancer Center
University of Colorado, Denver
University of Pittsburgh
National Institutes of Health Clinical Center (CC)
Harrison Clinical Research